Larissa M Bomfim Selected Research

Neoplasms (Cancer)

10/2021	Tingenone and 22-hydroxytingenone target oxidative stress through downregulation of thioredoxin, leading to DNA double-strand break and JNK/p38-mediated apoptosis in acute myeloid leukemia HL-60 cells.
1/2019	Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells.
1/2019	Ruthenium Complexes Containing Heterocyclic Thioamidates Trigger Caspase-Mediated Apoptosis Through MAPK Signaling in Human Hepatocellular Carcinoma Cells.
8/2014	ent-Kaurane diterpenes from the stem bark of Annona vepretorum (Annonaceae) and cytotoxic evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larissa M Bomfim Research Topics

Disease

4	Neoplasms (Cancer) 10/2021 - 08/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2019 - 03/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Acute Promyelocytic Leukemia 01/2019
1	Leukemia 01/2019

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2019
2	RutheniumIBA 01/2019 - 01/2019
2	CaspasesIBA 01/2019 - 01/2019
1	tingenoneIBA 10/2021
1	tingenin BIBA 10/2021
1	ThioredoxinsIBA 10/2021
1	TriterpenesIBA 10/2021
1	6-methyl-2-thiouracilIBA 01/2019
1	PlatinumIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	UracilIBA 01/2019
1	Concanavalin AIBA 01/2019
1	Volatile Oils (Essential Oils)IBA 03/2016
1	DiterpenesIBA 08/2014
1	Kaurane DiterpenesIBA 08/2014